Viatris Inc. Common Stock (VTRS)

About VTRS

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

30,000

Website

www.viatris.com/en

Fundamentals

1-day range

$16.2$16.78

Market cap

$18.97B

P/E (trailing)

—

P/E (forward)

6.17

EPS (trailing)

$-0.36

Dividend yield

2.70%

Beta

0.87

Avg. volume

10.24M

Ex-dividend date

August 21, 2026

Dividend pay date

September 16, 2026

Forecasts

8 analyst ratings

Viatris Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• VTRS

  Viatris Inc. Common Stock

  $16.34

  ▼ 3.26%
  Market cap $18.97BP/E —
  $9.43$18.39
• BBIO

  BridgeBio Pharma Inc. Common Stock

  $76.62

  ▼ 2.62%
  Market cap $16.20BP/E —
  $48.78$93.42
• ASND

  Ascendis Pharma A/S Ordinary Share

  $248.06

  ▼ 0.52%
  Market cap $15.49BP/E 26.94
  $186.05$282.15
• UTHR

  United Therapeutics Corporation Common Stock

  $515.57

  ▼ 2.34%
  Market cap $22.62BP/E 17.03
  $302.19$609.35
• ROIV

  Roivant Sciences Ltd. Common Shares

  $34.71

  ▼ 7.64%
  Market cap $25.38BP/E —
  $11.62$37.97
• ELAN

  Elanco Animal Health Incorporated Common Stock

  $24.12

  ▼ 1.51%
  Market cap $12.09BP/E —
  $17.11$27.98
• MDGL

  Madrigal Pharmaceuticals Inc. Common Stock

  $534.12

  ▼ 1.76%
  Market cap $11.79BP/E —
  $393.61$615

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Viatris' China Policy Concerns Overstated, UBS Says
  Yahoo · 8/19/2026
• 3 S&P 500 Stocks We Keep Off Our Radar
  Yahoo · 8/19/2026
• 3 Stocks Under $50 We’re Skeptical Of
  Yahoo · 8/18/2026
• 5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call
  Yahoo · 8/15/2026
• Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
  Yahoo · 8/13/2026
• Viatris (VTRS) Q2 2026 Earnings Call Transcript
  Yahoo · 8/13/2026
• Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update
  SeekingAlpha · 8/12/2026
• Is AMRX Stock a Buy as Growth Improves but Execution Risks Persist?
  Yahoo · 8/12/2026

• Leo Frans Groothuis · June 30, 2026 · Grant

  2.8K @ $15.88
• David S. Simmons · June 30, 2026 · Grant

  2.4K @ $15.88
• Paul Campbell · June 25, 2026 · Sale

  50.1K @ $16.17
• Goff Corinne Le · April 15, 2026 · Option Exercise

  3.6K
• Goff Corinne Le · April 15, 2026 · Option Exercise

  39.3K
• Goff Corinne Le · April 15, 2026 · Tax Withholding

  1.6K @ $13.86
• Goff Corinne Le · April 15, 2026 · Tax Withholding

  17.4K @ $13.86
• Paul Campbell · March 23, 2026 · Sale

  21.4K @ $13.28
• Goff Corinne Le · March 6, 2026 · Grant

  89.0K
• Goff Corinne Le · March 6, 2026 · Option Exercise

  2.2K
• Goff Corinne Le · March 6, 2026 · Option Exercise

  44.2K
• Goff Corinne Le · March 6, 2026 · Tax Withholding

  973 @ $14.16
• Goff Corinne Le · March 6, 2026 · Option Exercise

  2.2K
• Goff Corinne Le · March 6, 2026 · Tax Withholding

  19.6K @ $14.16
• Theodora Mistras · March 6, 2026 · Grant

  86.0K

Institutional Ownership

March 31, 2026

Total shares held

930.93M

Total value held

$11.29B

Institutional holders

1004